Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease

References

• Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis ;12 Suppl 2006; 1: S3–9
   Web of Science ®Google Scholar
• Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390–407
   PubMedGoogle Scholar
• Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521–33
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004; 22: 531–62
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Powrie F. The role of mucosal T lymphocytes in regulating intestinal inflammation. Springer Semin Immunopathol 2005; 27: 167–80
   PubMed Web of Science ®Google Scholar
• Elson CO, et al. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 2005; 206: 260–76
   PubMed Web of Science ®Google Scholar
• McCracken VJ, Lorenz RG. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001; 3: 1–11
   PubMed Web of Science ®Google Scholar
• Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol 2005; 174: 4453–60
   PubMed Web of Science ®Google Scholar
• Dahan S, Roth-Walter F, Arnaboldi P, Agarwal S, Mayer L. Epithelia: lymphocyte interactions in the gut. Immunol Rev 2007; 215: 243–53
   PubMed Web of Science ®Google Scholar
• Otte JM, Cario E, Podolsky DK. Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 2004; 126: 1054–70
   PubMed Web of Science ®Google Scholar
• Cario E, Podolsky DK. Intestinal epithelial TOLLerance versus inTOLLerance of commensals. Mol Immunol 2005; 42: 887–93
   PubMed Web of Science ®Google Scholar
• Harris G, KuoLee R, Chen W. Role of Toll-like receptors in health and diseases of gastrointestinal tract. World J Gastroenterol 2006; 12: 2149–60
   PubMed Web of Science ®Google Scholar
• Cario E, Podolsky DK. Toll-like receptor signaling and its relevance to intestinal inflammation. Ann NY Acad Sci 2006; 1072: 332–8
   PubMed Web of Science ®Google Scholar
• Ulevitch RJ. Therapeutics targeting the innate immune system. Nat Rev Immunol 2004; 4: 512–20
   PubMed Web of Science ®Google Scholar
• Bhattacharjee RN, Akira S. Toll-like receptor signaling: emerging opportunities in human diseases and medicine. Immunol Rev. 2005; 81–90
   Google Scholar
• Jobin C, Sartor RB. The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol 2000; 278: C451–62
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499–511
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Hafler DA. Suppressor T cells in human diseases. J Exp Med 2004; 200: 273–6
   PubMed Web of Science ®Google Scholar
• Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr Opin Immunol 2003; 15: 690–6
   PubMed Web of Science ®Google Scholar
• Wang RF. Functional control of regulatory T cells and cancer immunotherapy. Semin Cancer Biol 2006; 16: 106–14
   PubMed Web of Science ®Google Scholar
• Peng G, et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005; 309: 1380–4
   PubMed Web of Science ®Google Scholar
• Wang HY, et al. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 2004; 20: 107–18
   PubMed Web of Science ®Google Scholar
• Shibolet O, Podolsky DK. TLRs, in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction. Am J Physiol Gastrointest Liver Physiol 2007; 292: G1469–73
   PubMed Web of Science ®Google Scholar
• Melmed G, et al. Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut. J Immunol 2003; 170: 1406–15
   PubMed Web of Science ®Google Scholar
• Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007; 220: 251–69
   PubMed Web of Science ®Google Scholar
• Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, –87: a sixfold increase in incidence. Scand J Gastroenterol ;27 1962; 1992: 609–14
   Google Scholar
• Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3–11
   PubMed Web of Science ®Google Scholar
• Binder V. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 1970; 5: 627–32
   PubMed Web of Science ®Google Scholar
• Pedersen G, et al. A simple method to establish short-term cultures of normal human colonic epithelial cells from endoscopic biopsy specimens. Comparison of isolation methods, assessment of viability and metabolic activity. Scand J Gastroenterol 2000; 35: 772–80
   PubMed Web of Science ®Google Scholar
• Pedersen G, Andresen L, Matthiessen MW, Rask-Madsen J, Brynskov J. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium. Clin Exp Immunol 2005; 141: 298–306
   PubMed Web of Science ®Google Scholar
• Perner A, Andresen L, Pedersen G, Rask-Madsen J. Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells. Gut 2003; 52: 231–6
   PubMed Web of Science ®Google Scholar
• Hornung V, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531–7
   PubMed Web of Science ®Google Scholar
• Dheda K, et al. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 2004; 37: 112–19
   PubMed Web of Science ®Google Scholar
• Pedersen G, et al. Cytokine-induced impairment of short-chain fatty acid oxidation and viability in human colonic epithelial cells. Cytokine 2000; 12: 1400–4
   PubMed Web of Science ®Google Scholar
• Pedersen G, Saermark T, Bendtzen K, Brynskov J. Cultures of human colonic epithelial cells isolated from endoscopical biopsies from patients with inflammatory bowel disease. Effect of IFNgamma, TNFalpha and IL-1beta on viability, butyrate oxidation and IL-8 secretion. Autoimmunity 2000; 32: 255–63
   PubMed Web of Science ®Google Scholar
• Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis. 2008
   Google Scholar
• Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 2000; 68: 7010–17
   PubMed Web of Science ®Google Scholar
• Szebeni B, et al. Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease. Clin Exp Immunol 2008; 151: 34–41
   PubMed Web of Science ®Google Scholar
• De Jager PL, et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007; 8: 387–97
   PubMed Web of Science ®Google Scholar
• Hausmann M, et al. Toll-like receptors 2 and 4 are up-regulated during intestinal inflammation. Gastroenterology 2002; 122: 1987–2000
   PubMed Web of Science ®Google Scholar
• Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 2004; 25: 381–6
   PubMed Web of Science ®Google Scholar
• Nishiya T, DeFranco AL. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J Biol Chem 2004; 279: 19008–17
   PubMed Web of Science ®Google Scholar
• Agrawal S, Kandimalla ER. Synthetic agonists of Toll-like receptors 7, 8 and 9. Biochem Soc Trans 2007; 35: 1461–7
   PubMed Web of Science ®Google Scholar
• Heil F, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526–9
   PubMed Web of Science ®Google Scholar
• Triantafilou K, et al. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol 2005; 7: 1117–26
   PubMed Web of Science ®Google Scholar
• Satoh M, et al. Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy. Am Heart J 2007; 154: 581–8
   PubMed Web of Science ®Google Scholar
• Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F. Regulatory T cells and intestinal homeostasis. Immunol Rev 2005; 204: 184–94
   PubMed Web of Science ®Google Scholar
• Peggs KS, Quezada SA, Korman AJ, Allison JP. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. Curr Opin Immunol 2006; 18: 206–13
   PubMed Web of Science ®Google Scholar
• Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 2002; 39: 537–45
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229–41
   PubMed Web of Science ®Google Scholar
• Lee J, Mo JH, Shen C, Rucker AN., Raz E. Toll-like receptor signaling in intestinal epithelial cells contributes to colonic homoeostasis. Curr Opin Gastroenterol 2007; 23: 27–31
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126: 520–8
   PubMed Web of Science ®Google Scholar
• Kunsch C, Rosen CA. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 1993; 13: 6137–46
   PubMed Web of Science ®Google Scholar
• MacDermott RP, Sanderson IR, Reinecker H'C. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 1998; 4: 54–67
   PubMed Web of Science ®Google Scholar
• Westendorf AM, Bruder D, Hansen W, Buer J. Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in a transgenic autoimmune mouse model. Ann NY Acad Sci 2006; 1072: 401–6
   PubMed Web of Science ®Google Scholar
• Campbell N, Yio XY, So LP, Li Y, Mayer L. The intestinal epithelial cell: processing and presentation of antigen to the mucosal immune system. Immunol Rev 1999; 172: 315–24
   PubMed Web of Science ®Google Scholar
• Allez M, Brimnes J, Dotan I, Mayer L. Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells. Gastroenterology 2002; 123: 1516–26
   PubMed Web of Science ®Google Scholar